{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:02:33Z","timestamp":1785315753931,"version":"3.55.0"},"reference-count":9,"publisher":"Royal College of Psychiatrists","issue":"6","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Anxiety disorders are common and disabling.\u00a0Current drugs have limited efficacy, notable side-effects and little innovation. This editorial briefly reviews past, current and emerging anxiolytic treatments, including psychedelic-assisted therapies, and highlights key themes. There remains a major need for improved medications to reduce disability and improve quality of life.<\/jats:p>","DOI":"10.1192\/bjp.2026.10598","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:41:46Z","timestamp":1779950506000},"page":"500-503","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":1,"title":["Drugs for anxiety: from chloral hydrate to novel therapeutics"],"prefix":"10.1192","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3383-9294","authenticated-orcid":false,"given":"Peter M.","family":"Haddad","sequence":"first","affiliation":[{"name":"University of Manchester"},{"name":"Deakin University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"S0007125026105984_ref7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.19203"},{"key":"S0007125026105984_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31793-8"},{"key":"S0007125026105984_ref3","volume-title":"Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants","author":"Weller","year":"2005"},{"key":"S0007125026105984_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2025.09.011"},{"key":"S0007125026105984_ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113503509"},{"key":"S0007125026105984_ref1","unstructured":"1 Committee on Safety of Medicines. UK Government Bulletin to Prescribing Doctors, January 1988: Current Problems; Number 21: 1-2: Benzodiazepines, Dependence and Withdrawal Symptoms . Committee on Safety of Medicines, 1988."},{"key":"S0007125026105984_ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674"},{"key":"S0007125026105984_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(24)00133-0"},{"key":"S0007125026105984_ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.13481"}],"container-title":["The British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125026105984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:38:32Z","timestamp":1785314312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125026105984\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0007125026105984"],"URL":"https:\/\/doi.org\/10.1192\/bjp.2026.10598","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}